Product Information
GVOKE HYPOPEN 2-PK 1 MG/0.2 ML is a brand product labeled by Xeris Pharmaceuticals, Inc., priced at $1603.3466 per ML under NDC 72065012112. Its NADAC has been published 305 times since Oct 21, 2020.
FDA first approved this application on Sep 10, 2019.
Strength
1 mg/.2mL
Manufacturer
Xeris Pharmaceuticals, Inc.NDC
72065012112
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
GLUCAGONApproval Type
New Drug (NDA)
FDA Application
NDA212097FDA Approved
9/10/2019
On Market Since
9/10/2019
Pharmacological Classes
Price Statistics
The NADAC for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML has been published 305 times since Oct 21, 2020, and over the history we have for it it has risen 18.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1603.3466 per ML |
|---|---|
| All-time high | $1603.3466 (Aug 19, 2026) |
| All-time low | $1341.3857 (May 19, 2021) |
| 52-week high | $1603.3466 |
| 52-week low | $1552.5642 |
| Median price | $1465.7826 |
| Average price | $1470.7348 |
| Largest weekly change | +3.0% (Feb 15, 2023) |
| Weeks tracked | 305 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML?
The current National Average Drug Acquisition Cost (NADAC) for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML, manufactured by Xeris Pharmaceuticals, Inc., is $1603.3466 per ML (NDC 72065012112), effective Aug 19, 2026.
How has the price of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML changed over time?
Over the history we have for it, the NADAC for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML has risen 18.7%. It has been tracked across 305 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML?
Since Oct 21, 2020, the NADAC for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML has ranged from a low of $1341.3857 (May 19, 2021) to a high of $1603.3466 (Aug 19, 2026), with a median of $1465.7826 per ML.
Are there cheaper alternatives to GVOKE HYPOPEN 2-PK 1 MG/0.2 ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GVOKE PFS 1-PK 1 MG/0.2 ML SYR, is $1600.2289 per ML — about 0% below GVOKE HYPOPEN 2-PK 1 MG/0.2 ML.
Who manufactures GVOKE HYPOPEN 2-PK 1 MG/0.2 ML?
GVOKE HYPOPEN 2-PK 1 MG/0.2 ML (NDC 72065012112) is labeled by Xeris Pharmaceuticals, Inc., and CMS classifies it as a brand product.